Patent ID: 8335695

Claim:
A method comprising: identifying, on a processor, a comparable brand prescription drug to a generic prescription drug, the generic prescription drug being at least pharmaceutically comparable to the first comparable brand prescription drug; identifying, on the processor, a first drug availability of the comparable brand prescription drug, the first drug availability being associated with a first national drug code (NDC) 11 level; identifying, on the processor, a second drug availability of the comparable brand prescription drug, the second drug availability being associated with a second national drug code (NDC) 11 level, the second NDC 11 level being different than the first NDC 11 level, the first drug availability and the second drug availability being identical through a NDC 9 level; identifying, on the processor, a wholesale acquisition cost (WAC) of the first availability of the comparable brand prescription drug; identifying, on the processor, the WAC of the second availability of the comparable brand prescription drug; calculating, on the processor, a benchmark value for the generic prescription drug based on the WAC of the first availability and the second availability of the comparable brand prescription drug; and accessing, on the processor, a discount factor, a dispensing fee factor, a net payee rate, and a copayment factor; determining, on the processor, a reimbursement price of the generic prescription drug based on the benchmark value, the discount factor, the dispensing fee factor, the net payee rate, and the copayment factor, the reimbursement price being a price of the generic prescription drug associated with a PBM, the reimbursement price being a different amount than an out-of-pocket price paid by the participant for the generic prescription drug.